Bot Chart, page-12022

I think that when the announcement for BOT is finally made that it may not retrace like others have done.

There are a few key differences between BOT and others like:

- product already selling in Japan already making a substantial amount for Kaken

- by the time approval rolls around for us we may receive news of it also being approved for South Korea start to sell viak Kaken deal..coming up to a year since they initially penned that deal and it was reported they filed with regulators for approval





- we have inventory ready to sell, it's made and its just it's sitting there waiting to be placed in beautifully made boxes




- We have an exclusive agreement with UpScriptHealth who will make distribution and prescriptions much simpler with most patiences not having to leave their homes to even be prescribed it.



I think BOT has to finally find it's correct base above 0.40 prior to further confirmation of any sales whatsoever. it may spike well beyond and find its way back to the same region but I think when the sales begin to be reported whether that's the 1 quarter or sales or the 2nd, expect this sit at 0.80 as a bare minimum and that's using some of the more conservative numbers some are using here.

Enjoy thy weekends.